Side-by-side comparison of AI visibility scores, market position, and capabilities
Durham NC YC W23 Medicare-covered at-home pulmonary rehab for 16M US COPD patients shipping Kivo Kit; $475K MassMutual/Samsung NEXT-backed competing with Propeller Health for virtual respiratory rehabilitation at the 3-5% treatment gap.
Kivo Health is a Durham, North Carolina-based telehealth company — backed by Y Combinator (W23) with $475,000 raised from MassMutual Ventures, Samsung NEXT Ventures, Heuristic Capital, Quint Ventures, and SNR Ventures — providing Medicare-covered 8-week pulmonary rehabilitation programs to patients with chronic obstructive pulmonary disease (COPD), asthma, bronchitis, and other chronic lung conditions through an at-home telehealth delivery model that ships comprehensive Kivo Kits (containing an iPad pre-loaded with the Kivo platform and monitoring equipment) directly to patients' homes for virtual respiratory therapist sessions, structured exercise programs, and lung function monitoring. Founded in 2021 by founders with medical backgrounds and targeting the 16 million US patients with chronic lung conditions who represent $50 billion in annual healthcare spending.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.